Recent Updates — XWEL
XWELL, Inc. received a notice from Nasdaq on October 7, 2026, stating its common stock failed to maintain the required minimum closing bid price of $1.00 per share for 30 consecutive business days ending October 6, 2026. The company has an 180-day compliance period until April 5, 2027, to restore compliance by maintaining a closing price above $1.00 for ten consecutive trading days or by executing a reverse stock split at least ten business days before the deadline. Failure to regain compliance may result in delisting proceedings. XWELL operates as a digital health company focused on women's health and wellness.
On October 8, 2026, XpresTest, Inc., a subsidiary of XWELL, Inc., repurchased the final 279.5 outstanding shares of its common stock for an aggregate cash payment of approximately $2.7 million, or $9,634.09 per share. The transaction included the buyback of restricted stock awards held by Chairman Bruce T. Bernstein, CEO Ezra T. Ernst, and CFO Ian Brown, with all unvested shares becoming fully vested upon repurchase. This early completion simplifies XpresTest's capitalization in preparation for a previously announced sale to Express Wellness Group, LLC. The per-share price matches the valuation agreed upon by the buyer and XWELL under the Securities Purchase Agreement dated July 6, 2026. By paying these amounts upfront rather than treating them as sale expenses at closing, XWELL avoids dollar-for-dollar reductions in the purchase price payable by the Buyer. XWELL, Inc. operates in the healthcare diagnostics and wellness industry.
XWELL, Inc. announced on August 3, 2026, that President and CEO Ezra T. Ernst resigned from its Board of Directors and all committees to focus exclusively on his executive responsibilities. The resignation was not due to any disagreement with the company regarding operations or policies. To fill the resulting vacancy, the Board appointed Gerard Reid as a director effective immediately. Mr. Reid brings extensive experience in energy transition, capital markets, and corporate strategy, having previously served as Managing Director at Jefferies International and co-founder of Alexa Capital. He will receive an annual cash fee of $35,000 for his board service. XWELL operates in the technology, infrastructure, and emerging growth markets.
XWELL, Inc. entered into a Securities Purchase Agreement on July 6, 2026, to sell its equity interests in XpresSpa Holdings, LLC and XpresTest, Inc. to Express Wellness Group, LLC for a base purchase price of $13,000,000. The transaction includes $2,650,000 to be held in escrow and requires stockholder approval. XWELL will retain its health and wellness retail locations outside of airports. XWELL, Inc. operates in the health and wellness retail industry.